MinsigChoiMD

Oncology • Edgewood, KY

Gastrointestinal Cancer, Hematologic Oncology

Associate Professor, Stony Brook University School of Medicine

Join to view full profile

Dr. Choi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Choi's full profile

Already have an account?

Office
1 Medical Village Dr
Edgewood, KY 41017
Phone+1 859-301-4000

Fax+1 859-301-4001

Summary

Dr. Minsig Choi is an oncologist in Edgewood, KY and is affiliated with St. Elizabeth Edgewood. He received his medical degree from Far Eastern University Nicanor Reyes Medical Foundation and has been in practice 19 years. He also speaks multiple languages, including Korean. He specializes in gastrointestinal cancer and hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. He has more than 40 publications and over 500 citings.

Education & Training

Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2003 - 2006
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceResidency, Internal Medicine, 2000 - 2003
Far Eastern University Nicanor Reyes Medical FoundationClass of 1998

Certifications & Licensure

KY State Medical License 2022 - 2025
NY State Medical License 2014 - 2025
MI State Medical License 2003 - 2016
IL State Medical License 2000 - 2003
American Board of Internal Medicine Medical Oncology

Clinical Trials

E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer Start of enrollment: 2011 Nov 01
Terminated
Phase 1, Phase 2
Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) Start of enrollment: 2011 Aug 17
Completed
Phase 1
Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy Start of enrollment: 2012 Jun 01
Completed
Not Applicable
Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer Start of enrollment: 2012 Mar 01
Completed
Not Applicable
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer Start of enrollment: 2016 May 19
Active, not recruiting
Phase 2
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer Start of enrollment: 2019 May 10
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

ASO Visual Abstract: A Multicenter, Phase 1, Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery in P...
Minsig Choi, Megan M Harper, Prakash K Pandalai, Sherif R Z Abdel-Misih, Reema A Patel
Annals of Surgical Oncology. 2023-02-01
2 citations
A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritonea...
Minsig Choi, Megan M Harper, Prakash K Pandalai, Sherif R Z Abdel-Misih, Reema A Patel
Annals of Surgical Oncology. 2023-02-01
4 citations
Perioperative chemotherapy versus adjuvant chemotherapy strategies in resectable gastric and gastroesophageal cancer: A Markov decision analysis.
Minsig Choi, Sayaka Ishizawa, David N. Kraemer, Aaron R. Sasson, Eugene A. Feinberg
European Journal of Surgical Oncology. 2021-08-17

Press Mentions

Pancreatic Cancer Drug Developed by Stony Brook University Moves into Phase III Clinical TrialsOctober 23rd, 2019
Vitamin D Linked to Lower Risk of Colorectal CancerJune 20th, 2018

Other Languages

Korean